 |
| Nina DeLorenzo |
Emergent BioSolutions, life sciences company, has hired Nina DeLorenzo as senior VP-global public affairs.
The 25-year veteran joins the Gaithersburg, MD-based company from French pharmaceuticals giant Sanofi, where she was chief of staff, external affairs in Paris.
Earlier, DeLorenzo served as VP-international affairs at AbbVie, PA director at Pfizer, senior manager international PA at Schering-Plough and senior director communications & PA at PhRMA lobbying group.
She also did a nearly two-year stint at the State Dept. during the Bush II presidency.
At Emergent Bio, DeLorenzo is in charge of external affairs, corporate communications, advocacy and corporate social responsibility.
On April 2, the company unveiled a partnership with the US government to expedite development of a plasma-derived therapy for patients with COVID-19.
It received a $14.5M grant from the Biomedical Advanced Research and Development Authority to fund the effort.
As healthcare PR, crisis communications, and digital marketing continues to evolve, marketing and PR strategies must keep up with shifting patient expectations, emerging digital trends, and the rapid integration of artificial intelligence.
LaVoieHealthScience lands $4M five-year pact with General Services Administration to provide public relations, marketing and leadership training services to the federal government.
A trend is gaining pace to limit or ban words in the U.S. government. Here’s why putting restrictions on the language we use poses a dangerous path for companies and institutions.
Our dynamic, integrated information landscape demands an interconnected strategy that allows health communicators to amplify important messages and connect with audiences in efficient and meaningful ways.
Have a comment? Send it to
No comments have been submitted for this story yet.